Modulation of aldosterone levels by −344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension

This publication has 31 references indexed in Scilit:

• Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension
  Hypertension Research, 2013
• Aldosterone and cardiovascular disease: the heart of the matter
  Trends in Endocrinology & Metabolism, 2013
• Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
  Hypertension, 2010
• Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
  Annals of Internal Medicine, 2009
• Aldosterone Excess or Escape: Treating Resistant Hypertension
  The Journal of Clinical Hypertension, 2009
• Characterization of Resistant HypertensionAssociation Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume Expansion
  Archives of internal medicine (1960), 2008
• Resistant Hypertension: Diagnosis, Evaluation, and Treatment
  Hypertension, 2008
• Role of the Renin-Angiotensin-Aldosterone System and Proinflammatory Mediators in Cardiovascular Disease
  The American Journal of Cardiology, 2006
• Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
  New England Journal of Medicine, 2004
• Association Between Increased Plasma Levels of Aldosterone and Decreased Systemic Arterial Compliance in Subjects With Essential Hypertension
  American Journal of Hypertension, 1997